Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

  • There is currently no data for CAU

Trading Update

10 Oct 2024 07:00

RNS Number : 6181H
Centaur Media PLC
10 October 2024
 

Centaur Media plc

Incorporated in England and Wales

Registration number: 04948078

LEI: 2138005WK87G7DQRQI62

ISIN: GB0034291418

 

10 October 2024

Centaur Media Plc

("Centaur" or "the Company")

 

Trading Update

 

Centaur, an international provider of business intelligence, learning and specialist consultancy, provides a trading update.

 

As highlighted in the interim results in July, the marketing sector headwinds caused by macro-economic challenges have continued to drive restructurings in the marketing functions of many blue-chip customers of Xeim. This has led to the curtailment of marketing budgets and, although we have retained most of these customers, their spend has reduced. The prolonged impact of these challenges is materially reducing revenue and profit during the second half of 2024.

 

These headwinds are having a significant impact on Xeim's Econsultancy and Oystercatchers brands, and Xeim's non-strategic advertising revenue. More positively, revenue from our future growth drivers, The Lawyer, MW Mini MBA, Festival of Marketing's October event and Marketing Week's subscriptions, has continued to improve in the second half.

 

EBITDA in 2024 will decline as a result of the impact of the high operational gearing on Xeim's lower revenue and a change in revenue mix. EBITDA will also be lower than last year due to the 2024 planned ÂŁ1.3m investment in product, marketing and resources set out in our BIG27 strategy. This will accelerate the growth of our strategically valuable revenue over the next three years, in particular from The Lawyer, MW Mini MBA and Marketing Week's subscriptions.

 

The Board now expects the Company to achieve revenue of at least ÂŁ34m in 2024, at an adjusted EBITDA margin of approximately 15%, which is significantly below the current analyst consensus range. This revised expectation will also impact our revenue and profit expectations in 2025.

 

Outlook

We continue to review our go-to-market plans and maintain a focus on robust cost management. We retain a cautious outlook and do not anticipate that trading conditions for the affected parts of our business will improve in the near term.

 

Nonetheless, Centaur's strong balance sheet, with ÂŁ9.5m of net cash at 30 September 2024, and reliable cash conversion from our strategically valuable revenue streams, means that we are well positioned to manage this uncertainty. We will also continue to invest behind our strategy, as this will generate long-term value, while maintaining our progressive dividend policy which, as previously announced, is paying an interim ordinary dividend of 0.6 pence per share later this month.

 

Enquiries

Centaur Media plc 020 7970 4000

Swag Mukerji, Chief Executive Officer

Simon Longfield, Chief Financial Officer

 

Teneo

 

Zoë Watt / Oliver Bell

07713 157561 / 07917 221748

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUKARRSRURRUA
Date   Source Headline
25th Jul 201712:27 pmRNSResult of General Meeting
25th Jul 201711:00 amRNSDirectorate Change
19th Jul 20174:27 pmRNSDirector/PDMR Shareholding
14th Jul 20173:41 pmRNSNotice of Results
11th Jul 20172:51 pmRNSHolding(s) in Company
7th Jul 20172:47 pmRNSPublication of Circular
7th Jul 20177:00 amRNSProposed Disposal and Proposed Acquisition
30th Jun 20177:00 amRNSTotal Voting Rights
19th Jun 20174:15 pmRNSDirector/PDMR Shareholding
31st May 20177:00 amRNSTotal Voting Rights
24th May 201710:44 amRNSHolding(s) in Company
22nd May 201712:26 pmRNSDirector/PDMR Shareholding
9th May 20174:32 pmRNSResult of AGM
9th May 20177:00 amRNSTrading Statement
8th May 201710:32 amRNSHolding(s) in Company
28th Apr 20177:00 amRNSTotal Voting Rights
24th Apr 20174:22 pmRNSDirector/PDMR Shareholding
21st Apr 20171:27 pmRNSDirector/PDMR Shareholding
11th Apr 20173:37 pmRNSGrant of Award under LTIP
10th Apr 20174:40 pmRNSSecond Price Monitoring Extn
10th Apr 20174:35 pmRNSPrice Monitoring Extension
5th Apr 20173:09 pmRNSAnnual Report and Notice of AGM
3rd Apr 20179:21 amRNSTotal Voting Rights
29th Mar 20177:05 amRNSPotential disposal of Home Interest
29th Mar 20177:00 amRNSFinal Results
21st Mar 20173:07 pmRNSDirector/PDMR Shareholding
7th Mar 20173:37 pmRNSNotice of Results
6th Mar 201710:55 amRNSHolding(s) in Company
28th Feb 20179:38 amRNSTotal Voting Rights
21st Feb 201710:31 amRNSDirector/PDMR Shareholding
31st Jan 20174:00 pmRNSTotal Voting Rights
25th Jan 20177:00 amRNSTrading Update
23rd Jan 201710:07 amRNSHolding(s) in Company
19th Jan 20176:15 pmRNSDirector/PDMR Shareholding
30th Dec 20167:00 amRNSTotal Voting Rights
20th Dec 20164:18 pmRNSDirector/PDMR Shareholding
14th Dec 20167:00 amRNSTransaction in Own Shares
8th Dec 20167:00 amRNSTransaction in Own Shares
7th Dec 20167:00 amRNSTransaction in Own Shares
6th Dec 20169:13 amRNSTransaction in Own Shares
2nd Dec 20165:04 pmRNSTransaction in Own Shares
2nd Dec 20167:00 amRNSTransaction in Own Shares
30th Nov 20166:01 pmRNSTotal Voting Rights
30th Nov 20165:58 pmRNSTransaction in Own Shares
30th Nov 20167:00 amRNSTransaction in Own Shares
28th Nov 20165:39 pmRNSTransaction in Own Shares
25th Nov 20163:52 pmRNSTransaction in Own Shares
24th Nov 20165:23 pmRNSTransaction in Own Shares
24th Nov 20167:00 amRNSTransaction in Own Shares
23rd Nov 20167:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.